Mechanisms of action of sacubitril/valsartan on cardiac remodeling: a systems biology approach

npj Systems Biology and Applications

Volumn 3, Issue 1, 2017, Pages

  Iborra Egea, Oriol ^a   Gálvez Montón, Carolina ^a,b   Roura, Santiago ^a,b,c   Perea Gil, Isaac ^a   Prat Vidal, Cristina ^a,b   Soler Botija, Carolina ^a,b   Bayes Genis, Antoni ^a,b,d,e  

^a Germans Trias i Pujol Research Institute in Health Sciences   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c CENTER OF REGENERATIVE MEDICINE IN BARCELONA   (Spain)

^d HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^e UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85042145420     PISSN: None     EISSN: 20567189     Source Type: Journal    
DOI: 10.1038/s41540-017-0013-4     Document Type: Article

References (63)

1. Cheng, S. & Vasan, R. S. Advances in the epidemiology of heart failure and left ventricular remodeling. Circulation 124, 516–519 (2011)
2. Mann, D. L. & Bristow, M. R. Mechanisms and models in heart failure: the biomechanical model and beyond. Circulation 111, 2837–2849 (2005)
3. Galli, A. & Lombardi, F. Postinfarct left ventricular remodelling: a prevailing cause of heart failure. Cardiol. Res. Pract. 2016, 2579832 (2016)
4. Deedwania, P. C. & Carbajal, E. Evidence-based therapy for heart failure. Med. Clin. N. Am. 96, 915–931 (2012)
5. McMurray, J. J. et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N. Engl. J. Med. 371, 993–1004 (2014)
6. Ponikowski, P. et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur. J. Heart Fail. 18, 891–975 (2016)
7. Yancy, C. W. et al. 2016 ACC/AHA/HFSA focused update on new pharmacological therapy for heart failure: an update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation 134, 282–293 (2016)
8. Bayes-Genis, A., Barallat, J. & Richards, A. M. A test in context: neprilysin. Function, inhibition and biomarker. J. Am. Coll. Cardiol. 68, 639–653 (2016)
9. Bayés-Genís, A. Neprilysin in heart failure: from oblivion to center stage. JACC Heart Fail. 3, 637–640 (2015)
10. De la fuente, A. From “differential expression” to “differential networking”- identification of dysfunctional regulatory networks in diseases. Trends Genet. 26, 326–333 (2010)
11. Gómez-Serrano, M. et al. Proteome-wide alterations on adipose tissue from obese patients as age-, diabetes- and gender- specific hallmarks. Sci. Rep. 6, 25756 (2016)
12. Van Laere, S., Dirix, L. & Vermeulen, P. Molecular profiles to biology and pathways: a systems biology approach. Chin. J. Cancer 35, 53 (2016)
13. Waltemath, D. & Wolkenhauer, O. How modeling standards, software, and initiatives support reproducibility in systems biology and systems medicine. IEEE Trans. Biomed. Eng. 63, 1999–2006 (2016)
14. Prat-Vidal, C. et al. Identification of temporal and region-specific myocardial gene expression patterns in response to infarction in swine. PLoS One 8, 54785 (2013)
15. Liu, Y. et al. RNA‐Seq identifies novel myocardial gene expression signatures of heart failure. Genomics 105, 83–89 (2015)
16. Song, B. et al. Loss of angiotensin-converting enzyme 2 exacerbates myocardial injury via activation of the CTGF-fractalkine signaling pathway. Circ. J. 77, 2997–3006 (2013)
17. Altin, S. E. et al. Fractalkine: a novel cardiac chemokine? Cardiovasc. Res. 92, 361–362 (2011)
18. Ma, Y. et al. Neutrophil roles in left ventricular remodeling following myocardial infarction. Fibrogenesis Tissue Repair 6, 11 (2013)
19. Ito, H. et al. Role of angiotensin II type 1 receptor in the leucocytes and endothelial cells of brain microvessels in the pathogenesis of hypertensive cerebral injury. J. Hypertens. 19, 591–597 (2001)
20. Marino, F. et al. Angiotensin II type 1 receptor expression in polymorphonuclear leukocytes from high-risk subjects: changes after treatment with simvastatin. J. Cardiovasc. Pharmacol. 49, 299–305 (2007)
21. Naccache, P. H. Signalling in neutrophils: a retro look. ISRN Physiol. 2013 (2013)
22. Fejes-Toth, G. et al. Early aldosterone-regulated genes in cardiomyocytes: clues to cardiac remodeling? Endocrinology 148, 1502–1510 (2007)
23. Yoon, S. Y. et al. uPAR expression under hypoxic conditions depends on iNOS modulated ERK phosphorylation in the MDA-MB-231 breast carcinoma cell line. Cell Res. 16, 75–81 (2006)
24. Bessard, A. et al. MEK/ERK-dependent uPAR expression is required for motility via phosphorylation of P70S6K in human hepatocarcinoma cells. J. Cell. Physiol. 212, 526–536 (2007)
25. Kiyan, J. et al. Urokinase-receptor-mediated phenotypic changes in vascular smooth muscle cells require the involvement of membrane rafts. Biochem. J. 423, 343–351 (2009)
26. Ling, Q. et al. Inhibition of beta-myosin heavy chain gene expression in pressure overload rat heart by losartan and captopril. Zhongguo. Yao. Li. Xue. Bao. 18, 63–66 (1997)
27. Liu, X. et al. Modification of cardiac subcellular remodeling due to pressure overload by captopril and losartan. Clin. Exp. Hypertens. 21, 145–156 (1999)
28. Horckmans, M. et al. P2Y(4) nucleotide receptor: a novel actor in post-natal cardiac development. Angiogenesis 15, 349–360 (2012)
29. Von Lueder, T. G. & Krum, H. New medical therapies for heart failure. Nat. Rev. Cardiol 12, 730–740 (2015)
30. Packer, M. et al. Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure. Circulation 131, 54–61 (2015)
31. Von Lueder, T. G. et al. Angiotensin receptor neprilysin inhibitor LCZ696 attenuates cardiac remodeling and dysfunction after myocardial infarction by reducing cardiac fibrosis and hypertrophy. Circ. Heart Fail. 8, 71–78 (2015)
32. Desai, A. S. et al. Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients. Eur. Heart J. 36, 1990–1997 (2015)
33. Piek, A., de Boer, R. A. & Silljé, H. H. The fibrosis-cell death axis in heart failure. Heart. Fail. Rev. 21, 199–211 (2016)
34. Suematsu, Y. et al. LCZ696, an angiotensin receptor-neprilysin inhibitor, improves cardiac function with the attenuation of fibrosis in heart failure with reduced ejection fraction in streptozotocin-induced diabetic mice. Eur. J. Heart Fail. 18, 386–393 (2016)
35. Sonnhammer, E. L. L. & Östlund, G. InParanoid 8: orthology analysis between 273 proteomes, mostly eukaryotic. Nucleic. Acids. Res. 43, 234–239 (2015)
36. BarrettT et al. NCBI GEO: archive for functional genomics data sets‐‐update. Nucleic Acids Res. 41, 991–995 (2013)
37. Shi, W., Oshlack, A. & Smyth, G. K. Optimizing the noise versus bias trade‐off for Illumina whole genome expression BeadChips. Nucleic Acids Res. 38, 204 (2010)
38. Smyth, G. K. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 3, 1–25 (2004)
39. Smyth, G. K. limma: Linear Models for Microarray Data. Ch. Bioinformatics and Computational Biology Solutions Using R and Bioconductor. (eds Gentleman, R., Carey, V., Dudoit, S., Irizarry, R. & Huber, W.) 397–420 (Springer, 2005)
40. Yoav Benjamini, Y. H. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Series B Stat. Methodol. 57, 289–300 (1995)
41. Wright, S. P. Adjusted p‐values for simultaneous inference. Biometrics 48, 1005–1013 (1992)
42. Anaxomics Biotech SL. TPMS technology http://www.anaxomics.com/our-technology/tpms/#tpms (2016)
43. Pujol, A., Mosca, R., Farrés, J. & Aloy, P. Unveiling the role of network and systems biology in drug discovery. Trends Pharmacol. Sci. 31, 115–123 (2010)
44. Herrando-Grabulosa, M. et al. Novel neuroprotective multicomponent therapy for amyotrophic lateral sclerosis designed by networked systems. PLoS One 11, 0147626 (2016)
45. Gómez-Serrano, M. et al. Proteome-wide alterations on adipose tissue from obese patients as age-, diabetes- and gender-specific hallmarks. Sci. Rep. 6, 25756 (2016)
46. Perera, S., Artigas, L., Mulet, R., Mas, J. M. & Sardón, T. Systems biology applied to non-alcoholic fatty liver disease (NAFLD): treatment selection based on the mechanism of action of nutraceuticals. Nutrafoods 13, 61–68 (2014)
47. Russell S. & Norvig P. Artificial Intelligence: A Modern Approach 3rd edn (Prentice Hall, 2009)
48. Kirkpatrick, S., Gelatt, C. D. & Vecchi, M. P. Optimization by simulated annealing. Science 220, 671–680 (1983)
49. Goldberg, D. E. Genetic Algorithms in Search, Optimization, and Machine Learning 1st edn, (Addison-Wesley, 1989)
50. Wishart, D. S. et al. DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res. 1, 668–672 (2006)
51. Kanehisa, M. et al. From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Res. 34, 354–357 (2006)
52. Croft, D. et al. The Reactome pathway knowledgebase. Nucleic Acids Res. 42, 472–477 (2014)
53. Kerrien, S. et al. The IntAct molecular interaction database in 2012. Nucleic Acids Res. 40, 841–846 (2012)
54. Oughtred, R. et al. Use of the BioGRID database for analysis of yeast protein and genetic interactions. Cold Spring Harb. Protoc. 1 (2016)
55. Licata, L. et al. MINT, the molecular interaction database: 2012 update. Nucleic Acids Res. 40, 857–861 (2012)
56. Emily, P. Introduction to a general theory of elementary propositions. Am. J. Math. 43, 163–185 (1921)
57. Irving, H. Peirce’s truth-functional analysis and the origin of the truth table. Hist. Philos. Log. 33, 87–97 (2012)
58. Enderton H. A Mathematical Introduction to Logic, 2nd edn (Harcourt Academic, 2001)
59. Bishop, C. M. Pattern recognition and machine learning (Information Science and Statistics). (Springer, 2007)
60. Wishart et al. HMDB 3.0--The human metabolome database in 2013. Nucleic Acids Res. 41, 801–72012 (2013)
61. Rosenblatt, F. Principles of neurodynamics: Perceptrons and The Theory of Brain Mechanisms. (Spartan Books, 1961)
62. Rumelhart, D. E. et al. Parallel Distributed Processing: Explorations in the Microstructure of Cognition, Vol. 1 318–362 (MIT Press, 1986)
63. Cybenko, G. Approximation by superpositions of a sigmoidal function. Math. Control Signals Syst. 2, 303–314 (1989)